Juvenile Diabetes Research Foundation (JDRF) Australia - Health and Medical Research for Type 1 Diabetes

Overview

The Juvenile Diabetes Research Foundation (JDRF) Australia - Health and Medical Research for Type 1 Diabetes grant opportunity will provide $5 million funding over one (1) year from 2024-25  to facilitate and improve access to new treatments and therapies through clinical trials.  The funding was announced in the 2024-25 Budget as part of $22.1 million over two years (2024-25 to 2025-26) to continue support for preventive health and chronic disease research including patient and clinician services for Australians with chronic conditions. This Budget measure included providing direct research funding to JDRF Australia for 12 months to continue to facilitate clinical trial activities, boost next generation research capacity and deliver, implement and administer the Type 1 Diabetes (T1D) Clinical Research Network (CRN). Funding through this Budget measure supports the National Preventive Health Strategy 2021–2030 and the Government’s preventive health agenda to reduce pressure on the health and aged care system and ensure all Australians stay well for longer. The purpose of the grant opportunity is to support investment in health and medical research for T1D to facilitate and improve access to new treatments and therapies through clinical trials and the translation of research for people living with T1D. To view the grant opportunity documents, please select the red "Grant Opportunity Documents" button on the left-hand side.